News
PAVM
2.140
-21.61%
-0.590
iBio, Mesoblast, Kodiak Sciences among healthcare movers
IBio, Mesoblast, Kodiak Sciences among healthcare movers. S&P 500 Health Care Sector +0.18% to 1725.9. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index. S&p 500 Healthcare Equipment & Services among healthcare mover.
Seeking Alpha · 20h ago
Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)
TipRanks · 21h ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Avalo Therapeutics (NASDAQ:AVTX) shares rose 328.2% to $20.34 during Thursday's pre-market session. Xilio Therapeutic (XLO) stock moved upwards by 223.94% during the session. Akanda (AKAN) shares increased by 27.1% and INVO Bioscience (INVO) stock increased by 16.36%. NuCana (NCNA) stock declined by 19.8% in the pre- market.
Benzinga · 22h ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday. Avalo Therapeutics stock is rocketing more than 268% after announcing a $185 million private placement. Moving stocks this morning are public debuts, earnings reports and more. Ten of the biggest pre-market stocks moving shares this morning.
Investorplace · 22h ago
BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Reddit, Stoke Therapeutics
The Dow Jones Industrial Average was up 0.72% on Wednesday. Merck & Co hit record high as FDA approves therapy for rare lung condition. Reddit Inc up 46% in fifth day of trading. Netflix, Reddit, Stoke Therapeutics are among the day's top stocks.
Reuters · 1d ago
SMR, GCTS and GSIW among mid-day movers
On the Move SMR, GCTS and GSIW among mid-day movers. GCT Semiconductor Holding (GCTS) and iBio are among the biggest gainers in the SA market. SMR and GCSR among the largest losers.
Seeking Alpha · 1d ago
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
LuxUrban Hotels shares dipped 27.4% to $1.5523 on Wednesday. The company issued preliminary fourth-quarter revenue outlook below estimates. MariaDB plc shares climbed 70.4%. Lixte Biotechnology Holdings, Inc. Shares jumped 68.6% in mid-day session.
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Stoke Therapeutics (NASDAQ:STOK) shares increased by 46.1% to $15.03 during Wednesday's regular session. The company's market cap stands at $671.1 million. Nutriband stock rose 24.33% as the company's Q4 earnings came out yesterday. Lixte Biotechnology and Ontrak also moved upwards.
Benzinga · 1d ago
New Strong Buy Stocks for March 27th
NASDAQ · 1d ago
PAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q4 2023
PAVmed reported earnings per share of -$1.33. The company reported revenue of $1.05 million. This was 0.10% worse than the analyst estimate for the company to report revenue of £1.08 million. PAVmed is down 2.7% after the market close.
Investorplace · 2d ago
PAVmed Non-GAAP EPS of -$1.33 beats by $0.47, revenue of $1.05M beats by $0.02M
Earnings News PAVmed Non-GAAP EPS of -$1.33 beats by $0.47, revenue of $1.05M beats by £0.02M. PAvmed had cash and cash equivalents of $19.6 million as of December 31, 2022.
Seeking Alpha · 2d ago
*PAVmed 4Q Adj Loss/Shr $1.33 >PAVM
Dow Jones · 2d ago
*PAVmed 4Q Loss/Shr $1.98 >PAVM
Dow Jones · 2d ago
*PAVmed 4Q Rev $1M >PAVM
Dow Jones · 2d ago
Press Release: PAVmed Provides Business Update -2-
Common stockholders paid in stock and deemed dividends to common stockholders. The total number of common stock and preferred stock dividends paid to stockholders is more than 1,000,000. The number of preferred stock and common stock dividends is less than half of the total number paid in common stock. The average number of shares outstanding for common stock is 1,079,000 and the total stock value is $1.1 billion. The total value of the common stock, including preferred stock, is $9.2 billion.
Dow Jones · 2d ago
Press Release: PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results. Lucid's quarterly revenue increased 33 percent sequentially. Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio technologies. Conference call and webcast to be held tomorrow, March 27, 2024.
Dow Jones · 2d ago
PAVmed Q4 2024 Earnings Preview
Seeking Alpha · 2d ago
Notable earnings before Wednesday's open
Seeking Alpha · 2d ago
Earnings Scheduled For March 26, 2024
Bluebird bio is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. AIM ImmunoTech is estimated to report earnings for its fourth quarter. Elbit Systems is projected to report. Quarterly earnings at $1.38 per share.
Benzinga · 3d ago
Lucid Diagnostics Inc reports results for the quarter ended in December - Earnings Summary
Lucid Diagnostics Inc reports results for the quarter ended in December. Revenue rose 828.6% to $1.04 million from a year ago. The company reported a quarterly loss of $10.83 million. Lucid Diagnostic Inc shares had fallen by 22.7% this quarter.
Reuters · 3d ago
More
Webull provides a variety of real-time PAVM stock news. You can receive the latest news about Pavmed through multiple platforms. This information may help you make smarter investment decisions.
About PAVM
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.